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0929-6646/Copyright ª 2014, ElsevierBackground/Purpose: Noninvasive positive pressure ventilation has been regarded as a strat-
egy for improving exercise performance. Whether an increase in the ventilatory support level
improves exercise performance in patients who have received invasive ventilation is unknown.
The purpose of this study is to examine the effects of an additional level of pressure support
(PS) ventilation on exercise tolerance in patients undergoing prolonged mechanical ventilation
(PMV).
Methods: This study examined 15 patients who were undergoing PMV. All patients performed
an upper-arm exercise test at three PS levels: the baseline PS level (PS), a level 2 cmH2O higher
than the baseline level (PSþ2), and a level 4 cmH2O higher than the baseline level (PSþ4). The
physiological response, reasons for discontinuing the exercise test, and exercise duration were
recorded and analyzed.
Results: The tidal volume increased significantly from 271.7  54.7 mL to 398.3  88.7 mL at
the PSþ4 level (p Z 0.01). Significant differences in exercise duration were observed at
different PS levels. The exercise duration was significantly longer at the PSþ4 level than at
the PS and PSþ2 levels (146.3  139.9 seconds vs. 108.5  85.9 seconds vs. 72.8  43.9 sec-
onds, p Z 0.038) as their corresponding order. There were significant relationships between
resting respiratory rate and exercise duration at the PS (r Z 0.639, p Z 0.034) and PSþ2
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Exercise with additional pressure support in PMV 1205Conclusion: In patients undergoing PMV, an additional PS level of up to 4 cmH2O compared with
the baseline setting may help to improve exercise tolerance by prolonging exercise duration.
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Patients with prolonged mechanical ventilation (PMV) have
required at least 6 hours of mechanical ventilation for >21
consecutive days.1 Because of the advancement of critical
care medicine, the number of patients dependent on PMV
has rapidly increased worldwide.2 Studies have shown that
5e15% of patients with acute respiratory failure become
reliant on PMV. Furthermore, 67% of patients undergoing
PMV who were successfully weaned from a ventilator are
readmitted within 3 months after discharge.3
Patients undergoing PMV are commonly immobilized and
experience complications of critical illness and mechanical
ventilation, including muscle wasting and diaphragm
dysfunction, that may adversely affect their functional
statuses, ventilator weaning, and survival rates.4 Physical
inactivity and deconditioning are common in mechanically
ventilated patients with chronic respiratory failure.
Scheinhorn et al5 reported that 98.7% of patients were
bedridden at admission to post-intensive care unit (ICU)
weaning centers and that 69% of patients were still
bedridden at discharge from the weaning center. Even 12
months after discharge, only 19% of patients undergoing
PMV can be fully active during daily life.5 All of the afore-
mentioned complications may cause the mechanical
ventilation dependency rates and hospitalization duration
increase in patients undergoing PMV.6
Pulmonary rehabilitation programs have proved to
improve exercise tolerance and quality of life in patients
with chronic respiratory disease.7 In one study, 85.6% of
patients undergoing PMV were weaned from mechanical
ventilators and were able to stand and ambulate after
participating in a rehabilitation program.8 Exercise training
has been regarded as the cornerstone of pulmonary reha-
bilitation.9 Most studies on exercise limitation and training
have focused on spontaneously breathing patients with
chronic obstructive pulmonary disease (COPD) because of
the ventilatory and gas exchange impairment, along with
the cardiac and skeletal muscle dysfunction that accom-
pany this disease.10 However, few studies have investigated
exercise response and strategies for improving training ef-
ficiency in patients with PMV.
The American Thoracic Society (ATS) suggested that high-
intensity training produces substantial physiological benefits
and exert positive training effects on exercise capacity and
cardiopulmonary function, in patients with chronic respira-
tory diseases.9 However, high-intensity exercise is not al-
ways feasible in patients undergoing PMV, because they
experience impaired pulmonary function and weak muscle.
Applying additional noninvasive positive pressure ventilation
(NIPPV) during exercise may enhance the exercise tolerance
of nonintubated patients with COPD, and enable these pa-
tients to achieve greater training intensity because it acutelyreduces exertional dyspna.11,12 Applying additional NIPPV is
thus regarded as a strategy for improving exercise perfor-
mance according to the ATS statement on pulmonary reha-
bilitation.9 Therefore, for intubated patients with severe
cardiopulmonary impairment who are undergoing PMV, an
increase in mechanical ventilatory support during exercise
should improve exercise performance.
Pressure support ventilation (PSV) is a patient-triggered,
pressure-limited, and flow-cycled mode of mechanical
ventilation. When applied noninvasively to patients with
COPD, PSV has been proven to consistently improve exercise
endurance by reducing workload of breathing (WOB) during
exercise.13,14 Whether an additional increase in the baseline
pressure support (PS) level during exercise can improve ex-
ercise performance of patients undergoing PMV is unknown.
Therefore, the purpose of the study is to compare the effects
of three PS levels on the exercise tolerance and physiological
response of patients undergoing PMV.
Methods
Patients
We enrolled patients from a respiratory care center at the
Chang Gung Memorial Hospital, Tao-Yuan, Taiwan. After
patients were medically stable and their mechanical
ventilator settings were shifted from the assist-control
mode to pressure-support mode, we evaluated their eligi-
bility for the study. The inclusion criteria are listed as fol-
lows: (1) mechanical ventilation for >6 hours/day for >21
days and failure to be weaned from mechanical ventilation
in ICUs; (2) alertness and ability to cooperate with the re-
searchers; (3) medical stability [arterial blood gas value pH:
7.35e7.45, partial pressure of oxygen (PaO2): >60 mmHg at
40% fraction of inspiratory oxygen (FiO2), absence of signs
and symptoms of infection, and hemodynamic stability];
and (4) mechanical ventilation by PS with a mechanical
ventilation weaning program scheduled. Patients with
cancer or neurological or other systemic diseases were
excluded from the study. Patients unable to perform arm
ergometry or to maintain an upright sitting position
because of musculoskeletal problems, cardiovascular
instability, or other conditions were also excluded. The
study was conducted according to the principles estab-
lished in the Declaration of Helsinki, and informed consent
was obtained from the patients or their relatives before the
patients participated in the study.
Study design
During the initial screening visit, patients’ medical his-
tories, baseline weaning parameters [tidal volume (Vt),
1206 Y.-H. Chen et al.respiratory rate (RR), minute volume (MV), maximal inspi-
ratory pressure (Pimax), rapid shallow breathing index
(RSBI)] and mechanical ventilator settings were recorded.
All patients performed three exercise tests at three PS
levels in a random sequence over 3 consecutive days. The
three PS levels were defined as the baseline PS level (PS), a
PS level 2 cmH2O higher than the baseline PS level (PSþ2),
and a PS level 4 cmH2O higher than the baseline PS level
(PSþ4). The baseline levels of positive end expiratory
pressure (PEEP) and FiO2 were not changed throughout the
study.
Endurance arm exercise test
The patients underwent an upper extremity ergometer test
(Active Passive Train, Tzora Co, Kibbutz Tzora, Israel) in an
upright position in their beds. All patients were familiarized
with the cycling equipment prior to participating the study.
The exercise test protocol was selected according to the
method described by van’t Hul et al.15 Patients underwent
a constant-load, symptom-limited exercise test at fixed
resistance (approximately 10 W) in each test. They were
encouraged to perform the exercise to the point of intol-
erable shortness of breath, discomfort, or exhaustion. On
the basis of the American College of Chest Physicians
(ACCP) guidelines on cardiopulmonary exercise testing,16
the test was terminated if one of the following conditions
was observed: (1) heart rate (HR) > 80% of the age-
predicted maximal HR; (2) systolic blood pressure
(BP)  220 mmHg, or diastolic BP  120 mmHg; (3) a
decrease in BP  10 mmHg compared with the resting
status; (4) abnormalities such as ventricular tachycardia,
ventricular premature contraction, atrioventricular block,
or ventricular flutter were observed on an electrocardio-
gram; (5) severe angina; (6) signs of poor perfusion, or
SpO2  90% or  5% decrease in saturation of peripheral
oxygen (SpO2); (7) symptoms related to the nervous system
such as ataxia, dizziness, or confusion; (8) the patient
requested to stop; or (9) the patient reported fatigue or
shortness of breath (Borg scale > 5), wheezing, or arm
cramps. During each exercise test, vital signs and electro-
cardiogram were continually monitored using a bedside
computerized monitoring system (Philips Medizin System
GmbH 71034, Bo¨blingen, Germany) to evaluate the exercise
response of the patients. We recorded the total exercise
duration and physiological responses, including the HR, RR,
BP, and SpO2, as well as the reasons for discontinuing ex-
ercise during each exercise test.
Statistical analysis
Data were analyzed using the SPSS version 17.0 for Windows
(SPSS Inc., Chicago, IL, USA). Prior to all analyses, the one-
sample Kolmogorove Smirnov test was used to determine
the normality of the data. The results were expressed as
the mean  standard deviation for nominal distributions,
and as median and interquartile range for nonparametric
distributions.
To examine the effects of respiratory muscle strength on
exercise duration, study participants were divided into two
groups: high Pimax group: Pimax < 30 cmH2O (nZ 9); andlow Pimax group: Pimax > 30 cmH2O (n Z 6). A two-way
analysis of variance analysis was used to examine the dif-
ferences among conditions (PS, PSþ2, and PSþ4) and be-
tween groups. Pearson correlation coefficients between the
exercise endurance and weaning parameters were calcu-
lated. A stepwise regression analysis was used to determine
factors that contribute to the improvement of exercise




The demographic and clinical characteristics of the pa-
tients are presented in Table 1. Fifteen patients were
recruited and completed all exercise tests at the three PS
levels. The mean age of the patients was 73.1  11.2 years,
and the majority of patients were women (73%). Congestive
heart failure was diagnosed in approximately half of the
patients. Table 2 shows the weaning parameters and arte-
rial blood gas values of patients. Most of the patients
exhibited low Vt and hypercapnia prior to participating in
the study.
Physiological response during exercise tests at
various PS levels
Table 3 shows the physiological responses at the three PS
levels. The baseline PS level was 10.7  3 cmH2O. As the PS
level increased from baseline to PSþ4 levels, the Vt
significantly increased from 271.7  54.7 mL to
398.3  88.7 mL (p Z 0.001). Moreover, patients exhibited
significantly higher MV at the PSþ4 level than at the PS level
(7.8  2.2 L vs. 6.2  1.4 L, p Z 0.041). No differences
were observed in the RR, SpO2, and HR at rest among the
three PS levels. All patients completed the exercise at peak
volitional exertion at each level. Table 4 lists the reasons
for discontinuing exercise during each test. No significant
differences among the three PS levels in the changes of
vital signs at the end of the exercise test were observed.
Most exercise tests discontinued for more than one reason.
Shortness of breath was the most common reason for dis-
continuing the exercise test at all PS levels.
Effects of additional PS on exercise performance
Fig. 1 shows the exercise performance according to the PS
level. Significant differences in exercise duration among
the three PS levels were observed. The exercise duration
was significantly longer at the PSþ4 level compared with
the baseline PS level (146.3  139.9 seconds vs.
108.5  85.9 seconds vs. 72.8  43.9 seconds, p Z 0.038).
Compared with exercise endurance at the PS level, exercise
endurance was greater in nine patients (60%) at PSþ2 and in
14 patients (93%) at PSþ4. The percentage of improvement
in exercise endurance was 16% (13.6e129.7%) at the PSþ2
level and 36% (8.4e101.6%) at the PSþ4 level.
Fig. 2 shows a comparison of exercise duration between
the low and high Pimax groups. The high Pimax group could
Table 1 Characteristics of the study participants (n Z 15).
Study
participant No.









1 72 F Pulmonary hypertension 10 6 25 58
2 75 M COPD with AE 12 8 30 28
3 80 F Pneumonia, T-E fistula 14 8 35 114
4 68 F Congestive heart failure 14 8 40 48
5 85 F Pneumonia, congestive
heart failure
12 8 30 29
6 84 F Congestive heart failure 10 8 30 32
7 77 M COPD with AE 12 8 35 61
8 76 F Congestive heart failure 6 6 30 56
9 72 F Bronchiectasis 12 8 35 41
10 60 M Pneumonia, congestive
heart failure
6 6 30 62
11 73 F Chronic empyema 14 8 40 36
12 40 M Bronchiectasis 10 8 35 61
13 79 F Pneumonia, congestive
heart failure
8 6 30 84
14 78 F Pneumonia, congestive
heart failure
12 8 35 84
15 73 F Bronchiectasis 10 8 30 56
AEZ acute exacerbations; COPDZ chronic obstructive pulmonary disease; FZ female; FiO2: fraction of inspiratory oxygen; MZmale;
PEEP Z positive end-expiratory pressure; PS Z pressure support level; T-E Z tracheoesophageal.
Exercise with additional pressure support in PMV 1207exercise for a longer period than the low Pimax group could
at the three PS levels. However, the differences were not
statistically significant. In the low Pimax group, the pa-
tients exercised significantly longer at the PSþ4 level than
the PS level [66.0 (40.6e106.0) seconds vs. 42.0
(32.5e76.0) seconds, pZ 0.043]. No significant differences
were observed among the three PS levels in the high Pimax
group [PS vs. PSþ2 vs. PSþ4: 88.0 (62.5e135.3) seconds vs.Table 2 Weaning parameter and arterial blood gas values
of the study participants.
Values
Weaning parameters
Vt (mL) 160.0 (140e250)
RR (bpm) 22.0 (21.0e23.0)
MV (L) 3.7 (3.1e4.4)
Pimax (cmH2O) 30.0 (25.0e44.0)
RSBI (bpm/L) 137.0 (100.0e157.0)
Arterial blood gas
pH 7.44 (7.41e7.51)
PaCO2 (mmHg) 52.8 (38.0e68.2)
PaO2 (mmHg) 78.0 (70.1e88.1)
PaO2/FiO2 225.0 (209.1e326.7)
HCO3 (mEq/L) 33.0 (28.2e40.7)
BE 9.2 (4.7e15.6)
Data are presented as median (interquartile range).
FiO2 Z fraction of inspiratory oxygen; MV Z minute volume;
PaCO2 Z partial pressure of carbon dioxide; PaO2 Z partial
pressure of oxygen; BE Z base excess; Pimax Z maximal
inspiratory pressure; RR Z respiratory rate; RSBI Z rapid
shallow breathing index; Vt Z tidal volume.77.5 (47e138.5) seconds vs. 93.0 (56.5e214.0) seconds,
respectively, p Z 0.247].
Among the weaning parameters, significant correlations
were observed between the RR and exercise duration at the
PS (r Z 0.639, p Z 0.034) and PSþ2 levels (r Z 0.668,
p Z 0.025). No significant correlation was observed be-
tween vital sign changes and exercise duration at the three
PS levels. Significant correlations were also observed be-
tween improvement of exercise endurance at PSþ2 levels
and age (rZ 0.650, pZ 0.02), and between improvement
of exercise endurance at PSþ2 levels and PaO2
(r Z 0.630, p Z 0.02). No statistically significant corre-
lation coefficients were observed between improvement of
exercise endurance at PSþ4 levels and weaning parame-
ters, nor arterial blood gas data. In a stepwise multiple
regression analysis, age and PaO2 jointly significantly
contributed to improvement of exercise endurance when
the PSþ2 levels was applied during exercise explaining
68.3% of the variance in the outcome (p Z 0.02).Discussion
To our knowledge, this is the first study to investigate the
effect of additional PS levels on exercise tolerance in pa-
tients on PMV. In our study, the Vt increased significantly
when the PS level was increased. The patients exhibited
significantly longer exercise durations when they exercised
at the PSþ4 level.
The PS mode is often used for weaning in an ICU. At low
levels of support, this mode unloads the WOB that the
ventilator tubing imposes on the respiratory muscles. At
high levels of support, the ventilator can reduce respiratory
Table 3 Resting physiologic variables under different pressure support levels in patients on prolonged mechanical ventilation.
PS PSþ2 PSþ4 p
Vt (mL) 271.7  54.7 313.0  62.0 398.3  88.7 < 0.001
RR (bpm) 22.8  2.0 18.9  4.39 19.1  4.2 0.115
MV (L) 6.2  1.4 5.9  1.7 7.8  2.2 0.041
HR (bpm) 83.0  13.9 82.1  16.7 83.9  12.8 0.396
Mean arterial pressure (mmHg) 98.6  11.8 99.1  14.6 93.6  17.0 0.163
SpO2 (%) 96.6  1.7 96.0  2.2 97.3  2.2 0.311
Data are presented as mean  standard deviation.
HRZ heart rate; MVZ minute volume; PSZ patients exercise with PSV level at their baseline PS level (PS); PSþ2Z patients exercise
with PS level at 2 cmH2O greater than their baseline PS level; PSþ4 Z patients exercise with PS level at 4 cmH2O higher than their
baseline PS level; RR Z respiratory rate; SpO2 Z saturation of peripheral oxygen; Vt Z tidal volume.
1208 Y.-H. Chen et al.muscle activity, fatigue, and oxygen consumption.17 In our
study, exercise duration was significantly greater at the
PSþ4 level than at the PS level, especially in the low Pimax
group. The impaired respiratory muscle strength has been
reported as one of the reasons for exercise intolerance in
patients with chronic lung disease.13 During exercise, the
increased ventilatory demand may cause diaphragm
ischemia, thus inducing muscle metaboreflex and a subse-
quent sympathetic-mediated vasoconstriction in the exer-
cising peripheral muscles. Exercise of peripheral muscle
groups results in a quick rise in plasma lactate, which
further increased ventilatory load on respiratory muscle
and results in poor exercise tolerance.18 The results of the
current study confirm those of previous studies in which
additional ventilatory support results in reducing the load
of respiratory muscles, therefore improving ventilatory
efficiency and minimizing the impact of respiratory fatigue,
increasing exercise duration.11,12 Patients with low respi-
ratory muscle power (Pimax > 30 cmH2O) become
fatigued quickly during exercise, and may have more ben-
efits from additional pressure level in the improvement of
exercise duration.
Our study showed that the Vt increased significantly as
the level of PS increased. In addition, we observed an in-
verse relationship between the resting RR and exerciseTable 4 Peak exercise responses under different pressure supp
PS
PS level (cmH2O) 10.7  3
Peak HR (bpm) 93.8  18.9
Peak HR (% of predicted values) 63.9  11.5
Mean arterial pressure (mmHg) 93.8  12.1
SpO2 (%) 96.9  2.7
RR (bpm) 27.3  6.8
Reasons for stopping exercise
Arrhythmia
SpO2 drop 1/15 (6.7%)
Shortness of breath 13/15 (86.7%)
Exhaustion 9/15 (60%)
Muscle soreness/weakness 2/15 (13.4%)
Data are presented as mean  standard deviation.
HRZ heart rate; PSZ patients exercise with PSV level at their baselin
greater than their baseline PS level; PSþ4 Z patients exercise w
RR Z respiratory rate; SpO2 Z saturation of peripheral oxygen.duration at the PS and PSþ2 levels. Patients undergoing
PMV who had higher RR at resting status had shorter exer-
cise durations at the baseline and PSþ2 levels. However,
the relationship became less significant at the PSþ4 levels.
As ventilatory demand increased during exercise, patients
undergoing PMV with higher resting RR become dyspneic
quickly, leading to poor tolerance to exercise. The addi-
tional PS levels increased the Vt, and, thus enhanced ex-
ercise tolerance in PMV patients. Dreher et al19 reported
that the use of noninvasive proportional assist ventilation
during exercise led to an overall prolongation in the exer-
cise duration of obese patients. Although the ventilator
modes and patients characteristics vary among studies, all
authors agree that applying additional ventilatory assis-
tance increases the Vt and reduces the mechanical load of
the respiratory pump, thereby reducing RR during exercise.
These benefits are especially crucial for patients undergo-
ing PMV when engaging in exercise training and daily ac-
tivities. As the intensity or duration of exercise increases,
the respiratory system must work harder to generate
adequate ventilation to satisfy the increased demand. The
resting PS level may provide adequate support for the
respiratory system at rest but becomes inadequate when
the demand increases as the duration of exercise increases.
The increased Vt and exercise duration at the PSþ4 levelort levels in patients on prolonged mechanical ventilation.
PSþ2 PSþ4
12.8  2.8 13.6  2.6
91.0  14.3 89.3  13.5
62.1  8.1 60.8  8.7
95.3  12.9 92.8  10.3
96.7  2.4 96.5  1.9
27.3  9.1 25.9  9.4
1/15 (6.7%)
1/15 (6.7%) 1/15 (6.7%)
11/15 (73.3%) 10/15 (67.7%)
8/15 (53.3%) 6/15 (40.0%)
2/15 (13.4%) 2/15 (13.4%)
e PS level (PS); PSþ2Z patients exercise with PS level at 2 cmH2O
ith PS level at 4 cmH2O higher than their baseline PS level;
Figure 1 Effects of different pressure support level on ex-
ercise duration in patients on prolonged mechanical ventila-
tion. *p < 0.05, comparison between PS and PSþ4 levels. PS
(pressure support) Z patients exercise with pressure support
ventilation (PSV) level at their baseline PS level (PS);
PSþ2 Z patients exercise with PS level at 2 cmH2O greater
than their baseline PS level; PSþ4 Z patients exercise with PS
level at 4 cmH2O higher than their baseline PS level.
Exercise with additional pressure support in PMV 1209observed in the current study indicates that applying
additional PS during exercise may be a strategy for
improving efficiency of exercise training in patients un-
dergoing PMV.
In our study, age and PaO2 level significantly contributed
the improvement of exercise duration at the PSþ2 levels.
Patients who exhibited lower resting PaO2 were associated
with greater improvement in exercise duration at the PSþ2
levels (r Z 0.630, p Z 0.02), indicating an association
between the impaired ventilatory capacity of patients and
the positive effect of additional ventilatory support on
exercise ability. This result was consistent with that of a
previous study. Vitacca et al20 reported that patients with
COPD who received a high level of PS exhibited higher ox-
ygen saturation during exercise compared with statusFigure 2 Exercise endurance of low and high maximal
inspiratory pressure (Pimax) group under different PS levels.
*p < 0.05, comparison between PS and PSþ4 levels in low
Pimax group. PS (pressure support) Z patients exercise with
pressure support ventilation (PSV) level at their baseline PS
level (PS); PSþ2 Z patients exercise with PS level at 2 cmH2O
greater than their baseline PS level; PSþ4 Z patients exercise
with PS level at 4 cmH2O higher than their baseline PS level.without PS. Patients who exhibited lower PaO2 at rest have
a higher risk of being hypoxemic during exercise because of
their impaired oxygenation status.20 The additional venti-
latory support may improve alveolar ventilation by
increasing the Vt and reducing the RR during exercise, thus
prolonging exercise duration.
We adjust the PS level in increments of 2 cmH2O ac-
cording to the protocol of Chao et al.21 They developed a
weaning protocol for patients in a respiratory care center
and increased or reduced the PS levels by 2 cmH2O
depending on whether patients tolerated the current status
well or not for >24 hours. Therefore, we used 2 cmH2O as
an increment in each session. In addition, it has been re-
ported that an excessive PS level increases the risk of hy-
perinflation and discomfort in patients.22 Thus, we used the
level up to 4 cmH2O as the upper limit.Limitations
Our study has several limitations. Although the number of
patients in this study was comparable with that of previous
studies that yield with positive results,19,20 we are aware
that the small sample size may hamper interpretation of
the results. Additional studies with larger sample sizes are
required. Second, previous studies have reported that
additional NIPPV support may unload respiratory muscles,
improve peripheral muscle oxygenation, and reduce blood
lactate levels, thus reducing dyspnea.18,23e25 Our patients
exhibited a similar level of dyspnea but a prolonged exer-
cise duration at PSþ4 level. However, because of equip-
ment and technical limitations, we were unable to obtain
data on respiratory muscle activity and blood lactate
levels, which should be obtained in future studies. The
third limitation was the differences in diagnoses among the
patients. Congestive heart failure was diagnosed in almost
half of our patients (46.7%). A study has reported that the
effect of positive pressure varies between cardiac and
pulmonary diseases.26 Variations in underlying pathological
conditions of patients may partly explain the variations in
exercise duration. The last limitation is that although we
observed a significant improvement of exercise duration
with PSþ4 levels, whether a higher PS level would induced
longer exercise duration in patients on PMV remain ques-
tionable. Medadue et al24 reported that the exercise
duration as significantly longer at PS level of 20 cmH2O than
at sham PS level in patients with COPD, which is higher than
the mean value of PSþ4 group (13.6 cmH2O) in our study.
Because the degree of reduction on work of breathing is
related to the level of ventilator support, the PSþ4 level in
our study may be not the optimal level for patients un-
dergoing PMV. Further studies are needed to confirm the
optimal support level for patients undergoing PMV to
improve exercise performance.
Our study demonstrated that an increased PS level is
associated with a longer exercise duration compared with
the baseline PS level, especially in patients undergoing PMV
with low respiratory muscle strength (Pimax  30 cmH2O)
and rapid breath at rest. This beneficial effect might result
from an increase in the Vt, which is produced by an
increased PS level. In patients undergoing PMV who have
engaged in exercise, applying additional ventilatory
1210 Y.-H. Chen et al.support produces an immediate improvement in exercise
duration and may confer a training advantage. However,
additional studies are required to determine this
mechanism.
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